Brief: Statera Biopharma And Lay Sciences Inc Announce Intent To Enter Strategic Partnership To License The Manufacturing Rights To Certain Lay Sciences IgY Products
13/05/2022 12:42
May 13 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA AND LAY SCIENCES INC. ANNOUNCE INTENT TO
ENTER
STRATEGIC PARTNERSHIP TO LICENSE THE MANUFACTURING RIGHTS TO
CERTAIN LAY SCIENCES IGY PRODUCTS
Source text for Eikon: ID:nGNX1Lq6HT
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc